RENBP and neoplasm: It was reported that the adhesion to its substrate could be blocked by β1 integrin antibody and subsequently could sensitize diverse tumor types, including GC to cytotoxic drugs.3,32,33 To further elucidate MGr1-Ag in CAM-DR, MDR reversal agents, ASO, mAb, and siRNA of MGr1-Ag/37LRP were used to address it.